|
针刺调节肠腑功能治疗帕金森病抑郁的理论探讨
|
Abstract:
目的:基于中医“肝气郁滞、腑气不通”角度,探讨针刺调节肠腑功能,干预PDD的作用机制,以期为临床治疗PDD提供可行的治疗方法。方法:通过分析帕金森发病机制及神经递质分泌水平对于抑郁情绪的影响,联系中医“颤证”和“郁证”的有关理论以及肠道菌群对于帕金森发病机制相关性的研究。结合针刺对于神经递质、肠道菌群和炎症反应的调节作用,探讨针刺调节肠腑功能对于帕金森抑郁治疗的理论支持。结果:帕金森病抑郁(Parkinson’s Disease Depression, PDD)患者常伴有胃肠失调症状,较易被忽视。肠道与中枢之间的神经联系参与胃肠道疾病和神经退行性疾病,α-突触核蛋白(α-syn)的聚集、纹状体多巴胺(DA)缺乏、5-羟色胺(5-HT)下降、去甲肾上腺素(NE)减少、神经炎症都与肠道菌群失调有关。已有的实验证明,微生物–肠–脑轴的神经内分泌网络是PDD的发病机制之一。中医治疗PDD安全、有效,且优势显著。针刺是治疗PDD的方式之一,具有增加优势菌群、减少致病菌,维持肠道内环境稳态,调节神经递质等作用。结论:脑肠轴理论为中医治疗PPD提供了思路与方法,从脑–肠相关性探究针刺治疗PDD具有实际临床意义。尽管此次研究论述了肠道菌群与帕金森病抑郁的理论联系和针刺治疗帕金森病抑郁改善肠腑功能的可行性,但对针刺治疗帕金森病抑郁缺乏临床统一的选穴配穴方案,以及具体的针刺手法的阐述。
Objective: Based on the perspective of “liver qi stagnation and fu qi obstruction” in traditional Chinese medicine, therefore, this paper discusses the mechanism of acupuncture regulating intestinal function and intervening PDD, in order to provide a feasible treatment method for clinical treatment of PDD. Methods: By analyzing the pathogenesis of Parkinson’s disease and the influence of neurotransmitter secretion level on depressive mood, the relevant theories of “fibrillation syndrome” and “depression syndrome” in traditional Chinese medicine, as well as the correlation of intestinal flora on the pathogenesis of Parkinson’s disease. Combined with the regulatory effect of acupuncture on neurotransmitters, intestinal microbiota and inflammatory response, this paper explored the theoretical support of acupuncture in regulating intestinal function for the treatment of Parkinson’s depression. Results: Depression is one of the common clinical symptoms of Parkinson’s disease. Patients with Parkinson’s disease depression (PDD) are often accompanied by symptoms of gastrointestinal disorders and are more likely to be ignored. The neural connection between the gut and the center is involved in diseases of the gastrointestinal tract and neurodegenerative diseases. Aggregation of α-synuclein (α-syn), striatal dopamine (DA) deficiency, decreased 5-Hydroxytryptophan (5-HT), decreased norepinephrine (NE), and neuroinflammation are all associated with intestinal dysbiosis. Previous experiments have shown that the neuroendocrine network of the microbiome-gut-brain axis is one of the pathogenesis of PDD. TCM treatment of PDD is safe, effective, and has significant advantages. By the
[1] | Ray, S. and Agarwal, P. (2020) Depression and Anxiety in Parkinson Disease. Clinics in Geriatric Medicine, 36, 93-104. |
[2] | 李星, 张保朝, 赵伟, 等. 帕金森病合并抑郁症与25-羟基维生素D的相关性研究[J]. 国际精神病学杂志, 2020, 47(5): 900-903. |
[3] | Westfll, S., Lomis, N., Kahouli, I., et al. (2017) Microbiome, Probiotics and Neurodegenerative Disease: Deciphering the Gut Brain Axis. Cellular and Molecular Life Sciences, 74, 3769-3787. |
[4] | Elena, P., Sergio, V., Teresa, M., et al. (2020) The Noradrenergic System in Parkinson’s Disease. Frontiers in Pharmacology, 11, Article 435. |
[5] | 阿地拉·阿吉, 张丞, 唐潇潇, 等. 丙戊酸钠缓释片联合富马酸喹硫平治疗双相情感障碍的疗效与安全性[J]. 中国医师杂志, 2021, 23(7): 1093-1096. |
[6] | 孙孟艳, 秦合伟, 王梦楠, 等. 基于肠道微生物群探讨阿尔茨海默病认知障碍的中医辨治[J]. 中医学报, 2022, 37(11): 2337-2342. |
[7] | 熊啸, 徐天舒. 基于脑肠互动探析中医药改善功能性消化不良的作用机制[J]. 陕西中医, 2023, 44(2): 224-228. |
[8] | Sun, M.F., Zhu, Y.L., Zhou, Z.L., et al. (2018) Neuroprotective Effects of Fecal Microbiota Transplantation on MPTP-Induced Parkinson’s Disease Mice: Gut Microbiota, Glial Reaction and TLR4/TNF-α Signaling Pathway. Brain, Behavior, and Immunity, 70, 48-60. |
[9] | 赵晓娟, 权青云, 孟宏涛, 等. α-突触核蛋白与帕金森病伴发快速眼动期睡眠行为障碍相关性研究[J]. 陕西医学杂志, 2022, 51(2): 191-194. |
[10] | 秦丽清, 吴林, 潘艺彬, 等. 基于肠道菌群探讨从脾胃论治帕金森病[J]. 辽宁中医药大学学报, 2022, 24(10): 98-102. |
[11] | 沈聪, 王坚. 原发性帕金森病与胃肠道起源假说研究进展[J]. 中国临床神经科学, 2019, 27(2): 216-222. |
[12] | Brudek, T. (2019) Inflammatory Bowel Diseases and Parkinson’s Disease. Journal of Parkinson’s Disease. 9, S331-S344. |
[13] | 郭鹏, 王相斌, 尤素伟, 等. α-突触核蛋白对帕金森小鼠β-arrestin2表达水平的影响及意义[J]. 中华老年医学杂志, 2022, 41(5): 586-590. |
[14] | 吉家日, 孙恒聪, 林道冠, 等. 血清α-突触核蛋白水平与帕金森病抑郁患者抑郁状态及运动障碍严重程度的相关性研究[J]. 中国临床神经科学, 2022, 30(5): 542-549. |
[15] | 郭轩彤, 陈祖昕, 曹旭, 等. 肠道功能障碍诱发帕金森病的机制[J]. 华中科技大学学报(医学版), 2021, 50(4): 538-543. |
[16] | 李亭, 郭姗姗, 李倩, 等. 粪菌移植在帕金森病治疗中的作用研究进展[J]. 河北医药, 2021, 43(2): 280-284+289. |
[17] | 刘晨喆. 多巴胺能系统与炎症性肠病[J]. 生理科学进展, 2021, 52(2): 146-150. |
[18] | Caputi, V. and Giron, M.C. (2018) Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease. International Journal of Molecular Sciences, 19, 1689. |
[19] | Wei, L., Hu, X., Yuan, Y., et al. (2018) Abnormal Ventral Tegmental Area-Anterior Cingulate Cortex Connectivity in Parkinson’s Disease with Depression. Behavioural Brain Research, 347, 132-139. |
[20] | 李慧英, 李延峰. 帕金森病相关的情绪障碍[J]. 中国神经免疫学和神经病学杂志, 2019, 26(6): 454-459. |
[21] | Schapira, A.H.V., Chaudhuri, K.R. and Jenner, P. (2017) Non-Motor Features of Parkinson Disease. Nature Reviews Neuroscience, 18, 435-450. |
[22] | Lukić, I., Getselter, D., Koren, O., et al. (2019) Role of Tryptophan in Microbiota-Induced Depressive-Like Behavior: Evidence from Tryptophan Depletion Study. Frontiers in Behavioral Neuroscience, 13, Article No. 123. |
[23] | 刘斌, 杨浩辉, 任伯, 等. 丁苯酞联合美多芭对帕金森病伴抑郁模型小鼠黑质纹状体II型髓系细胞触发受体及小胶质细胞炎症标志物表达的影响[J]. 陕西医学杂志, 2022, 51(12): 1477-1482. |
[24] | 黄忠明. 酸枣仁汤对帕金森病抑郁大鼠行为学及脑内5-HT表达的影响[J]. 中国老年学杂志, 2022, 42(12): 3089-3091. |
[25] | Li, Z., Liu, W., Xiao, C., et al. (2020) Abnormal White Matter Microstructures in Parkinson’s Disease and Comorbid Depression: A Whole-Brain Diffusion Tensor Imaging Study. Neuroscience Letters, 735, Article ID: 135238. |
[26] | 邓猛. 定颤安神方联合针刺治疗帕金森病对患者认知功能和神经递质水平的影响[J]. 中外医学研究, 2021, 19(28): 128-131. |
[27] | 侯鑫磊, 唐强, 朱路文, 等. 针刺联合重复经颅磁刺激疗法治疗帕金森病的疗效及对miR-103a、miR-214表达的影响[J]. 中西医结合心脑血管病杂志, 2022, 20(7): 1308-1311. |
[28] | 任炜霞, 刘毅, 武前福, 等. 基于调控小胶质细胞探讨中医药治疗帕金森病机制[J]. 陕西中医, 2023, 44(3): 341-344. |
[29] | Silva, Y.P., Bernardi, A. and Frozza, R.L. (2020) The Role of Short-Chain Fatty Acids from Gut Microbiota in Gut-Brain Communication. Frontiers in Endocrinology, 11, Article No. 25. https://doi.org/10.3389/fendo.2020.00025 |
[30] | Lubomski, M., Tan, A.H., Lim, S., Holmes, A.J., Davis, R.L. and Sue, C.M. (2019) Parkinson’s Disease and the Gastrointestinal Microbiome. Journal of Neurology, 267, 2507-2523. https://doi.org/10.1007/s00415-019-09320-1 |
[31] | Mottawea, W., Chiang, C., Mühlbauer, M., Starr, A.E., Butcher, J., Abujamel, T., et al. (2016) Altered Intestinal Microbiota-Host Mitochondria Crosstalk in New Onset Crohn’s Disease. Nature Communications, 7, Article No. 13419. https://doi.org/10.1038/ncomms13419 |
[32] | Liu, S., Guo, R., Liu, F., Yuan, Q., Yu, Y. and Ren, F. (2020) Gut Microbiota Regulates Depression-Like Behavior in Rats through the Neuroendocrine-Immune-Mitochondrial Pathway. Neuropsychiatric Disease and Treatment, 16, 859-869. https://doi.org/10.2147/ndt.s243551 |
[33] | 刘鹏鸿, 张克让. 肠道菌群失调致抑郁症发病机制的研究进展[J]. 中国微生态学杂志, 2019, 31(4): 475-479. |
[34] | Kelly, J.R., Borre, Y., O’Brien, C., Patterson, E., El Aidy, S., Deane, J., et al. (2016) Transferring the Blues: Depression-Associated Gut Microbiota Induces Neurobehavioural Changes in the Rat. Journal of Psychiatric Research, 82, 109-118. https://doi.org/10.1016/j.jpsychires.2016.07.019 |
[35] | 彭高强, 文颖娟, 吕建琴, 等. 基于肠道菌群探讨抑郁症从脾论治的作用机制[J]. 中华中医药学刊, 2022, 40(10): 36-39. |
[36] | 张静, 王凯旋, 盛放, 等. 孤独症谱系障碍儿童肠道菌群多样性与Treg-Th17的相关性研究[J]. 中华全科医学, 2020, 18(8): 1324-1326+1330. |
[37] | Caspani, G. and Swann, J. (2019) Small Talk: Microbial Metabolites Involved in the Signaling from Microbiota to Brain. Current Opinion in Pharmacology, 48, 99-106. https://doi.org/10.1016/j.coph.2019.08.001 |
[38] | 沈馨, 孙志宏. 微生物-肠-脑轴与神经系统疾病的研究进展[J]. 生物工程学报, 2021, 37(11): 3781-3788. |
[39] | Fang, P., Kazmi, S.A., Jameson, K.G. and Hsiao, E.Y. (2020) The Microbiome as a Modifier of Neurodegenerative Disease Risk. Cell Host & Microbe, 28, 201-222. https://doi.org/10.1016/j.chom.2020.06.008 |
[40] | Angelucci, F., Cechova, K., Amlerova, J. and Hort, J. (2019) Antibiotics, Gut Microbiota, and Alzheimer’s Disease. Journal of Neuroinflammation, 16, Article No. 108. https://doi.org/10.1186/s12974-019-1494-4 |
[41] | Duman, R.S., Sanacora, G. and Krystal, J.H. (2019) Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments. Neuron, 102, 75-90. https://doi.org/10.1016/j.neuron.2019.03.013 |
[42] | 马敬, 仲照希, 岳凌峰, 等. 阿立哌唑改善帕金森病伴发抑郁模型大鼠行为学及能量代谢[J]. 华中科技大学学报(医学版), 2023, 52(2): 200-205. |
[43] | 唐江岳, 向桃, 杜辕滨, 等. 基于“脑-肠-菌轴”的“针-膏-摩”疗法治疗脑卒中后便秘的临床研究[J]. 中医药学报, 2019, 47(2): 108-111. |
[44] | 孙哲, 艾宗耀, 李峥嵘, 等. 针刺联合中药复方治疗卒中后抑郁的疗效观察及对患者血清5-HT、NE和BDNF水平的影响[J]. 上海针灸杂志, 2022, 41(4): 342-347. |
[45] | 梅氏清心(Thi Thanh Tam Mai). “疏肝调神”针法对胆碱能过活化CUMS模型大鼠CORT、NE的影响研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2020. |
[46] | 肖伟, 章显宝, 王震, 等. 针刺对卒中后抑郁大鼠脑组织神经递质及5-羟色胺转运体、5-羟色胺1A受体、去甲肾上腺素α2受体的影响[J]. 针刺研究, 2016, 41(6): 528-534. |
[47] | 臧平, 王烨林, 方锐. 调和阴阳针灸联合穴位按摩治疗顽固性失眠症的疗效及对焦虑、嗜睡症状和神经递质水平的影响[J]. 四川中医, 2023, 41(2): 205-208. |
[48] | 宋蕙杉, 白妍, 王顺. 针刺对帕金森抑郁模型大鼠的影响[J]. 中医学报, 2021, 36(2): 349-355. |
[49] | 韩其琛, 孙忠人, 尹洪娜, 等. 基于“脑肠轴”探讨针刺治疗脑卒中后认知障碍的作用机制[J]. 中医药信息, 2022, 39(4): 10-15+46. |
[50] | 于美月. 不同电针对帕金森病抑郁模型大鼠肠道菌群AWCD值及Shannon指数影响的实验研究[D]: [硕士学位论文]. 哈尔滨: 黑龙江省中医药科学院, 2018. |
[51] | 王照钦, 钟蕊, 高崚, 等. 针刺对帕金森病模型小鼠肠道菌群多样性的调节作用[J]. 中华中医药杂志, 2020, 35(5): 2265-2270. |
[52] | 杨育林. “调任通督”针法对轻中度产后抑郁临床疗效差异及肠道菌群影响的研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2021. |
[53] | 齐妍妍, 王爱平. 炎症性肠病患者心理社会适应的研究进展[J]. 实用临床医药杂志, 2018, 22(20): 139-142. |
[54] | 吴盛各, 时雅辉, 李铺, 等. 帕金森病患者抑郁水平与神经免疫及炎症状态的相关性研究[J]. 山西医药杂志, 2019, 48(22): 2763-2765. |
[55] | 赵雅. 针刺对抑郁大鼠前额叶皮层炎性细胞因子和小胶质细胞的影响[D]: [硕士学位论文]. 北京: 北京中医药大学, 2020. |
[56] | 何川. “标本配穴”预针刺调控肠道菌群-LPS-神经炎性反应对衰老模型大鼠学习记忆认知功能障碍的机制研究[D]: [博士学位论文]. 武汉: 湖北中医药大学, 2021. |
[57] | 马振旺, 梁浩, 赵兵等. 透穴刺法对帕金森病焦虑大鼠杏仁核TNF-α和IL-10表达的影响[J]. 陕西中医, 2021, 42(9): 1171-1174. |
[58] | 崔向琴, 徐运启, 高敏. 高敏从肝论治帕金森病抑郁经验[J]. 广州中医药大学学报, 2022, 39(3): 664-668. |
[59] | 黄瑞欧, 王省, 盛蕾, 等. 基于“肝主筋脉, 调畅情志”中医辨治帕金森病抑郁的思路和方法[J]. 世界科学技术-中医药现代化, 2022, 24(3): 933-938. |
[60] | 袁盈, 蔡向红, 陈枫. “颅底七穴”改善帕金森病伴发抑郁临床疗效观察[J]. 中国老年保健医学, 2020, 18(6): 27-30. |
[61] | 武家竹, 韩佳炜, 张曼, 等. 针灸治疗中风后便秘的机制研究进展[J]. 针灸临床杂志, 2023, 39(1): 105-109. |